Monitoring of anticoagulant effects of dabigatran in everyday practice: First experience in 32 Polish patients

Polskie Archiwum Medycyny Wewnetrznej

Volumn 124, Issue 9, 2014, Pages 487-489

  Czubek, Urszula ^a   Góralczyk, Tadeusz ^a   Zalewski, Jarosław ^a,b   Undas, Anetta ^a,b  

^a Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; KIDNEY FUNCTION; MALE; AGED; ANALOGS AND DERIVATIVES; ATRIAL FIBRILLATION; BLOOD; CLINICAL PRACTICE; MIDDLE AGED; POLAND; PROCEDURES;

AGED; ANTITHROMBINS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; DRUG MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POLAND;

EID: 84907689006     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2415     Document Type: Article

References (6)

1. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361: 1139-1151.
2. Kornej J, Potpara T, Lip GYH. Anticoagulation management in nonvalvular atrial fibrillation: current and future directions. Pol Arch Med Wewn. 2013; 123: 623-634.
3. Reilly PA, Lehr T, Haertter S, et al. RE-LY Investigators. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). J Am Coll Cardiol. 2014; 63: 321-328.
4. Dansirikul C, Lehr T, Liesenfeld KH, et al. A combined pharmacometric analysis of dabigatran etexilate in healthy volunteers and patients with atrial fibrillation or undergoing orthopaedic surgery. Thromb Haemost. 2012; 107: 775-785.
5. Douxfils J, Dogné JM, Mullier F, et al. Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate. Thromb Haemost. 2013; 110: 543-549.
6. Undas A, Pasierski T, Windyga J, Crowther M. Practical therapeutic aspects of new oral anticoagulants use in atrial fibrillation. Pol Arch Med Wewn. 2014; 124: 124-135.